A Covid-19 testing company has reported a record turnover as its profits topped £6m during its latest financial year.
Liverpool-headquartered BioGrad, which also provides lab and clinical training, has posted a turnover of £17m for the 12 months to the end of September 2021, a rise of 80%, as well as an EBITDA of £6m, up 70%.
In a statement, the business said the growth was "largely driven" by the demand for Covid-19 testing, which has enabled the firm to diversify into other areas and "build on its medical diagnostics expertise and reputation".
